缩写名/全名 |
CANCERS
Cancers |
||||||||||||||||||||
ISSN号 | 2072-6694 | ||||||||||||||||||||
研究方向 | - | ||||||||||||||||||||
影响因子 | 2015:0, 2016:0, 2017:5.326, 2018:6.162, 2019:6.126, | ||||||||||||||||||||
出版国家 | Switzerland | ||||||||||||||||||||
出版周期 | |||||||||||||||||||||
年文章数 | 2020 | ||||||||||||||||||||
出版年份 | 2009 | ||||||||||||||||||||
是否OA | Yes | ||||||||||||||||||||
审稿周期(仅供参考) | |||||||||||||||||||||
录用比例 | |||||||||||||||||||||
投稿链接 | https://login.mdpi.com/login?_target_path=https%3A%2F%2Fsusy.mdpi.com%2Fuser%2Flogin%3FauthAll%3Dtrue | ||||||||||||||||||||
投稿官网 | https://www.mdpi.com/journal/cancers | ||||||||||||||||||||
h-index | 53 | ||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2072-6694%5BISSN%5D | ||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Examination of Independent Prognostic Power of Gene Expressions and Histopathological Imaging Features in Cancer. Author: Zhong T1, Wu M2, Ma S3. Journal: Cancers (Basel). 2019 Mar 13;11(3). pii: E361. doi: 10.3390/cancers11030361. PubMed DOI |
2. | Engagement with tNOX (ENOX2) to Inhibit SIRT1 and Activate p53-Dependent and -Independent Apoptotic Pathways by Novel 4,11-Diaminoanthra[2,3-b]furan-5,10-diones in Hepatocellular Carcinoma Cells. Author: Lin CY1, Islam A2, Su CJ3,4, Tikhomirov AS5,6, Shchekotikhin AE7,8, Chuang SM9, Chueh PJ10,11,12, Chen YL13,14. Journal: Cancers (Basel). 2019 Mar 24;11(3). pii: E420. doi: 10.3390/cancers11030420. PubMed DOI |
3. | The Contributions of Prostate Cancer Stem Cells in Prostate Cancer Initiation and Metastasis. Author: Mei W1,2,3,4,5, Lin X6,7,8,9, Kapoor A10,11,12, Gu Y13,14,15,16, Zhao K17,18,19,20, Tang D21,22,23,24. Journal: Cancers (Basel). 2019 Mar 27;11(4). pii: E434. doi: 10.3390/cancers11040434. PubMed DOI |
4. | CX Chemokine Receptor 7 Contributes to Survival of KRAS-Mutant Non-Small Cell Lung Cancer upon Loss of Epidermal Growth Factor Receptor. Author: Liu B1, Song S2,3, Setroikromo R4, Chen S5, Hu W6, Chen D7, van der Wekken AJ8, Melgert BN9,10, Timens W11, van den Berg A12, Saber A13, Haisma HJ14. Journal: Cancers (Basel). 2019 Mar 30;11(4). pii: E455. doi: 10.3390/cancers11040455. PubMed DOI |
5. | Identification of Cancer Stem Cell Molecular Markers and Effects of hsa-miR-21-3p on Stemness in Esophageal Squamous Cell Carcinoma. Author: Gao Z1, Liu H2, Shi Y3, Yin L4, Zhu Y5, Liu R6. Journal: Cancers (Basel). 2019 Apr 11;11(4). pii: E518. doi: 10.3390/cancers11040518. PubMed DOI |
6. | Increase Paclitaxel Sensitivity to Better Suppress Serous Epithelial Ovarian Cancer via Ablating Androgen Receptor/Aryl Hydrocarbon Receptor-ABCG2 Axis. Author: Chung WM1,2, Ho YP3, Chang WC4,5, Dai YC6, Chen L7,8, Hung YC9,10, Ma WL11,12,13. Journal: Cancers (Basel). 2019 Apr 2;11(4). pii: E463. doi: 10.3390/cancers11040463. PubMed DOI |
7. | Regulation of Cell Signaling Pathways by Berberine in Different Cancers: Searching for Missing Pieces of an Incomplete Jig-Saw Puzzle for an Effective Cancer Therapy. Author: Farooqi AA1, Qureshi MZ2, Khalid S3, Attar R4, Martinelli C5, Sabitaliyevich UY6, Nurmurzayevich SB7, Taverna S8, Poltronieri P9, Xu B10. Journal: Cancers (Basel). 2019 Apr 4;11(4). pii: E478. doi: 10.3390/cancers11040478. PubMed DOI |
8. | TRPC3 Regulates the Proliferation and Apoptosis Resistance of Triple Negative Breast Cancer Cells through the TRPC3/RASA4/MAPK Pathway. Author: Wang Y1, Qi YX2, Qi Z3, Tsang SY4,5,6,7. Journal: Cancers (Basel). 2019 Apr 18;11(4). pii: E558. doi: 10.3390/cancers11040558. PubMed DOI |
9. | The Role of HOX Transcription Factors in Cancer Predisposition and Progression. Author: Li B1, Huang Q2, Wei GH3. Journal: Cancers (Basel). 2019 Apr 12;11(4). pii: E528. doi: 10.3390/cancers11040528. PubMed DOI |
10. | Histopathological Imaging⁻Environment Interactions in Cancer Modeling. Author: Xu Y1, Zhong T2, Wu M3, Ma S4. Journal: Cancers (Basel). 2019 Apr 24;11(4). pii: E579. doi: 10.3390/cancers11040579. PubMed DOI |
|
|